media – Page 518 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

iBeat’s $5.5M funding paves way for summer launch of cardio wearable

San Francisco-based wearable tech company iBeat announced today that it has closed an additional $5.5 million in seed funding, bringing its total round to $10 million.
- Source: MobiHealthNews
- 674
- May 3, 2018
Company Insights mHealth wearables
Nokia is selling its digital health business back to the co-founder of Withings

Nokia has announced plans to sell its struggling health tech business back to Éric Carreel, co-founder of Withings, the French startup Nokia bought in 2016.
- Source: The Verge
- 586
- May 3, 2018
Company Insights digital health
Aetna rides Medicare Advantage growth, ACA exit to profitable Q1

Aetna has added 250,000 Medicare Advantage members in the first quarter of 2018 on its way to a profitable first quarter as it looks to close a deal with CVS Health.
- Source: FierceHealthcare
- 414
- May 2, 2018
Company Insights
AI-powered doctor assistant Suki lands $20M in funding

Suki, a startup that makes an AI-powered and voice-enabled digital assistant for doctors, has just landed $20 million in a funding round led by Venrock, with participation from First Round, Social Capital, and Marc Benioff.
- Source: MobiHealthNews
- 573
- May 2, 2018
AI Company Insights
Fitbit will use Google Cloud to make its data available to doctors

Fitbit announced yesterday that it plans to utilize Google’s new Cloud Healthcare API, in order to continue its push into the world of serious healthcare devices. It’s a bit of a no-brainer as far as partnerships go.
- Source: Tech Crunch
- 871
- May 2, 2018
Company Insights mHealth wearables
Manufacturing hiccup in China trips up Sanofi’s vaccine sales momentum

After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports of the pediatric shot Pentaxim, thanks to vaccine batches that failed to pass inspection. That move hobbled the shot's sales—and dragged the rest of the unit down, too.
- Source: fiercepharma
- 626
- May 2, 2018
Company Insights Pentaxim Sanofi
China hands out landmark nod with lightning speed

GSK’s Cervarix and Merck’s previous version of Gardasil took about 10 years to reach the Chinese market. (Merck)
- Source: fiercepharma
- 913
- May 2, 2018
CFDA Gardasil GSK New Approvals
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer

First Filing Acceptance for an Anti-PD-1 Therapy in Cervical Cancer
- Source: investors.merck
- 632
- May 2, 2018
cervical cancer FDA keytruda Merck
Gilead inks $90m deal with Verily to create “molecular map” of inflammatory disease

Gilead Sciences (NSDQ:GILD) is reportedly slated to pay Alphabet’s Verily Life Sciences $90 million over three years to analyze cells from patients with rheumatoid arthritis, inflammatory bowel disease and lupus-related diseases.
- Source: drugdeliverybusiness
- 631
- May 2, 2018
Gilead Market Views rheumatoid arthritis
7 Side Effects Of Hormonal Birth Control Nobody Told You About

To be clear, this doesn't mean you are likely to experience these side effects after going on birth control. But if you do notice any of them after you start, there could be a connection there, and it's worth talking to your doctor if you don't like the effects you're experiencing or notice anything out of the ordinary. Here are a few possible side effects of hormonal birth control that you may not have been told about.
- Source: drugdu
- 437
- April 30, 2018
Hormonal Birth Control side effects

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.